VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
-8.18%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$63.6M
AUM Growth
+$63.6M
(-18%)
Cap. Flow
-$3.71M
Cap. Flow
% of AUM
-5.83%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Passage Bio
PASG
|
$3.2M |
| 2 |
Aligos Therapeutics
ALGS
|
$510K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
CRISPR Therapeutics
CRSP
$4.71B
| $23.4M | 36.84% | 498,558 | – | – |
|
|
CTNM
2
Contineum Therapeutics
CTNM
$293M
| $17.6M | 27.64% | 918,163 | – | – |
|
3
Repare Therapeutics
RPTX
$71.7M
| $9.1M | 14.32% | 2,646,657 | – | – |
|
4
Skye Bioscience
SKYE
$108M
| $7.85M | 12.35% | 2,007,704 | – | – |
|
5
Adverum Biotechnologies
ADVM
$64.6M
| $3.56M | 5.6% | 506,821 | – | – |
|
|
GRTS
6
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $2.07M | 3.25% | 3,561,150 | – | – |
|
|
7
Aligos Therapeutics
ALGS
$73.3M
| – | – | -1,457,937 | Closed | -$510K |
|
|
8
Passage Bio
PASG
$22.7M
| – | – | -4,026,417 | Closed | -$3.2M |
|